Investigative site

Columbus, Ohio 43235

0 studies enrolling now · 9 studies all time

What they study most

AIS, Alport Syndrome, Covid19, Focal Segmental Glomerulosclerosis, Obesity, Obesity and Type 2 Diabetes, Overweight, Pancreatic Cancer, Postherpetic Neuralgia

Studies at this site

• Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus — Completed
• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Running, not enrolling
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis — Completed
• Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19. — Stopped early
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• NBP in Adult Patients With Acute Ischemic Stroke (AIS) — Completed
• Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia — Completed